Brief: Procept Biorobotics Q4 revenue USD 23.8 million
28/02/2023 23:33
Feb 28 (Reuters) - Procept Biorobotics Outlook FY revenue USD 125 million. * Outlook FY adjusted EBITDA USD -70.5 million * Outlook FY gross margin 53% * Q4 net income USD -28.2 million * Q4 adjusted EBITDA USD -21.7 million * Q4 gross margin 45% * Q4 revenue USD 23.8 million
Recent news on PROCEPT BioRobotics
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Brief: Procept Biorobotics Corporation Enters Third Amendment To Loan And Security Agreement With Cibc